PL1773829T3 - Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne - Google Patents
Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczneInfo
- Publication number
- PL1773829T3 PL1773829T3 PL05790816T PL05790816T PL1773829T3 PL 1773829 T3 PL1773829 T3 PL 1773829T3 PL 05790816 T PL05790816 T PL 05790816T PL 05790816 T PL05790816 T PL 05790816T PL 1773829 T3 PL1773829 T3 PL 1773829T3
- Authority
- PL
- Poland
- Prior art keywords
- amino
- preparation
- therapeutic use
- tropane derivatives
- tropane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0408372A FR2873693B1 (fr) | 2004-07-29 | 2004-07-29 | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
PCT/FR2005/001856 WO2006021657A1 (fr) | 2004-07-29 | 2005-07-20 | Derives d'amino-tropane, leur preparation et leur application en therapeutique |
EP05790816A EP1773829B1 (fr) | 2004-07-29 | 2005-07-20 | Derives d'amino-tropane, leur preparation et leurs applications en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1773829T3 true PL1773829T3 (pl) | 2009-06-30 |
Family
ID=34947491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL05790816T PL1773829T3 (pl) | 2004-07-29 | 2005-07-20 | Pochodne aminotropanu, ich wytwarzanie oraz ich zastosowania terapeutyczne |
Country Status (26)
Country | Link |
---|---|
US (1) | US7569582B2 (pl) |
EP (1) | EP1773829B1 (pl) |
JP (1) | JP2008508242A (pl) |
KR (1) | KR20070047803A (pl) |
CN (1) | CN101010320B (pl) |
AR (1) | AR050019A1 (pl) |
AT (1) | ATE417846T1 (pl) |
AU (1) | AU2005276355B2 (pl) |
BR (1) | BRPI0513923A (pl) |
CA (1) | CA2574517A1 (pl) |
CY (1) | CY1108878T1 (pl) |
DE (1) | DE602005011818D1 (pl) |
DK (1) | DK1773829T3 (pl) |
ES (1) | ES2319918T3 (pl) |
FR (1) | FR2873693B1 (pl) |
HR (1) | HRP20090160T1 (pl) |
IL (1) | IL180797A (pl) |
MX (1) | MX2007001023A (pl) |
PE (1) | PE20060575A1 (pl) |
PL (1) | PL1773829T3 (pl) |
PT (1) | PT1773829E (pl) |
RU (1) | RU2389727C2 (pl) |
SI (1) | SI1773829T1 (pl) |
TW (1) | TW200617005A (pl) |
UY (1) | UY29040A1 (pl) |
WO (1) | WO2006021657A1 (pl) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2873691B1 (fr) * | 2004-07-29 | 2006-10-06 | Sanofi Synthelabo | Derives d'amino-piperidine, leur preparation et leur application en therapeutique |
FR2873690B1 (fr) * | 2004-07-29 | 2006-10-13 | Sanofi Synthelabo | Derives d'oxopiperidine, leur preparation et leur application en therapeutique |
WO2007028770A1 (en) * | 2005-09-05 | 2007-03-15 | Neurosearch A/S | Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease |
EP2305263B1 (en) * | 2007-06-07 | 2012-09-19 | Novartis AG | Stabilized amorphous forms of imatinib mesylate |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
SI2074120T1 (sl) * | 2007-10-25 | 2010-06-30 | Exelixis Inc | Tropan spojine |
US8153653B2 (en) * | 2010-06-22 | 2012-04-10 | Hoffmann-La Roche Inc. | Amido-tropane derivatives |
US8846666B2 (en) | 2011-03-08 | 2014-09-30 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR199901570T2 (xx) * | 1996-10-30 | 1999-09-21 | Schering Corporation | N�rokinin antagonistleri olarak piperazin t�revleri |
US5968929A (en) * | 1996-10-30 | 1999-10-19 | Schering Corporation | Piperazino derivatives as neurokinin antagonists |
US7169777B2 (en) * | 2001-01-23 | 2007-01-30 | Eli Lilly And Company | Melanocortin receptor agonists |
WO2003007949A1 (en) * | 2001-07-18 | 2003-01-30 | Merck & Co., Inc. | Bridged piperidine derivatives as melanocortin receptor agonists |
EP1469851B1 (en) * | 2002-01-23 | 2006-10-11 | Eli Lilly And Company | Melanocortin receptor agonists |
-
2004
- 2004-07-29 FR FR0408372A patent/FR2873693B1/fr not_active Expired - Fee Related
-
2005
- 2005-07-20 SI SI200530620T patent/SI1773829T1/sl unknown
- 2005-07-20 KR KR1020077004658A patent/KR20070047803A/ko not_active Application Discontinuation
- 2005-07-20 CA CA002574517A patent/CA2574517A1/fr not_active Abandoned
- 2005-07-20 BR BRPI0513923-6A patent/BRPI0513923A/pt not_active IP Right Cessation
- 2005-07-20 AT AT05790816T patent/ATE417846T1/de active
- 2005-07-20 JP JP2007523110A patent/JP2008508242A/ja active Pending
- 2005-07-20 ES ES05790816T patent/ES2319918T3/es active Active
- 2005-07-20 PL PL05790816T patent/PL1773829T3/pl unknown
- 2005-07-20 DK DK05790816T patent/DK1773829T3/da active
- 2005-07-20 CN CN2005800292441A patent/CN101010320B/zh not_active Expired - Fee Related
- 2005-07-20 WO PCT/FR2005/001856 patent/WO2006021657A1/fr active Application Filing
- 2005-07-20 RU RU2007107372/04A patent/RU2389727C2/ru not_active IP Right Cessation
- 2005-07-20 AU AU2005276355A patent/AU2005276355B2/en not_active Ceased
- 2005-07-20 PT PT05790816T patent/PT1773829E/pt unknown
- 2005-07-20 DE DE602005011818T patent/DE602005011818D1/de active Active
- 2005-07-20 EP EP05790816A patent/EP1773829B1/fr active Active
- 2005-07-20 MX MX2007001023A patent/MX2007001023A/es active IP Right Grant
- 2005-07-27 AR ARP050103112A patent/AR050019A1/es not_active Application Discontinuation
- 2005-07-28 TW TW094125585A patent/TW200617005A/zh unknown
- 2005-07-28 UY UY29040A patent/UY29040A1/es not_active Application Discontinuation
- 2005-08-01 PE PE2005000887A patent/PE20060575A1/es not_active Application Discontinuation
-
2007
- 2007-01-18 IL IL180797A patent/IL180797A/en not_active IP Right Cessation
- 2007-01-25 US US11/626,973 patent/US7569582B2/en not_active Expired - Fee Related
-
2009
- 2009-03-17 CY CY20091100292T patent/CY1108878T1/el unknown
- 2009-03-17 HR HR20090160T patent/HRP20090160T1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
PT1773829E (pt) | 2009-03-26 |
IL180797A (en) | 2011-02-28 |
KR20070047803A (ko) | 2007-05-07 |
US7569582B2 (en) | 2009-08-04 |
SI1773829T1 (sl) | 2009-06-30 |
PE20060575A1 (es) | 2006-08-02 |
AU2005276355B2 (en) | 2011-08-25 |
RU2389727C2 (ru) | 2010-05-20 |
EP1773829A1 (fr) | 2007-04-18 |
MX2007001023A (es) | 2007-04-16 |
US20070191361A1 (en) | 2007-08-16 |
FR2873693A1 (fr) | 2006-02-03 |
DE602005011818D1 (de) | 2009-01-29 |
ATE417846T1 (de) | 2009-01-15 |
BRPI0513923A (pt) | 2008-05-20 |
CA2574517A1 (fr) | 2006-03-02 |
EP1773829B1 (fr) | 2008-12-17 |
FR2873693B1 (fr) | 2006-09-15 |
TW200617005A (en) | 2006-06-01 |
IL180797A0 (en) | 2007-06-03 |
JP2008508242A (ja) | 2008-03-21 |
CN101010320A (zh) | 2007-08-01 |
DK1773829T3 (da) | 2009-04-20 |
CN101010320B (zh) | 2011-11-16 |
AU2005276355A1 (en) | 2006-03-02 |
RU2007107372A (ru) | 2008-09-10 |
HRP20090160T1 (en) | 2009-05-31 |
ES2319918T3 (es) | 2009-05-14 |
AR050019A1 (es) | 2006-09-20 |
UY29040A1 (es) | 2006-02-24 |
WO2006021657A1 (fr) | 2006-03-02 |
CY1108878T1 (el) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200700705B (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
IL178402A0 (en) | 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof | |
IL180770A0 (en) | Oxopiperidine derivatives, preparation and therapeutic use thereof | |
ZA200703876B (en) | 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof | |
IL181069A0 (en) | Sulphonamide derivatives , their preparation and their therapeutic application | |
IL180682A0 (en) | N-hydroxamide derivatives, their preparation and use | |
TWI350286B (en) | Alkylpiperazine- and alkylhomopiperazine-carboxylate derivatives, their preparation and their application in therapy | |
IL177047A0 (en) | Oxazole derivatives, preparation and therapeutic use thereof | |
EP1828223A4 (en) | Novel betulin derivatives, their preparation and their use | |
TWI350287B (en) | Acylaminothiazole derivatives, their preparation and their therapeutic application | |
HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
IL180797A0 (en) | Amino-tropane derivatives, preparation thereof and therapeutic use thereof | |
PL1776340T3 (pl) | Pochodne B-(1H-indolilo)-1H-indolo-2-karboksyamidów, ich wytwarzanie i zastosowanie ich w lecznictwie | |
IL184008A0 (en) | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments | |
PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
IL190519A0 (en) | 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof | |
IL182385A0 (en) | Pyridine derivatives and the preparation and the therapeutic use thereof | |
HK1074444A1 (en) | Acyloxypyrrolidine derivatives, preparation and therapeutic use thereof | |
IL180867A0 (en) | Pyrrole derivatives, their preparation and their therapeutic use | |
ZA200704806B (en) | Novel betulin derivatives, preparation thereof and use thereof | |
TWI340642B (en) | Acylaminothiazole derivatives, preparation and therapeutic application thereof | |
IL191892A0 (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
HK1107340A1 (en) | 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof | |
ZA200704650B (en) | 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments | |
SI1525198T1 (sl) | Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP |